ArticleJournal of the National Cancer Institute2023

Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancer.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.